WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005035794) DETECTION OF PRRSV
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/035794    International Application No.:    PCT/US2004/033350
Publication Date: 21.04.2005 International Filing Date: 08.10.2004
IPC:
C12Q 1/68 (2006.01)
Applicants: TETRACORE, INC. [US/US]; 11 Firstfield Road, Suite C, Gaithersburg, MD 20878 (US) (For All Designated States Except US).
CALLAHAN, Johnny, D. [US/US]; (US) (For US Only).
NELSON, William, Max [US/US]; (US) (For US Only)
Inventors: CALLAHAN, Johnny, D.; (US).
NELSON, William, Max; (US)
Agent: LAU, Kawai; Townsend and Townsend and Crew LLP, 12730 High Bluff Drive, Suite 400, San Diego, CA 92130 (US)
Priority Data:
60/510,375 09.10.2003 US
Title (EN) DETECTION OF PRRSV
(FR) DETECTION DU SDRP
Abstract: front page image
(EN)This invention provides compositions and methods for the detection of porcine reproductive and respiratory syndrome viruses (PRRSV). The invention provides oligonucleotides containing sequences complementary to those in ORF 7 and the 3’-UTR (untranslated region) of PRRSV which oligonucleotides may be use to detect the presence of PRRSV sequence, and thus the presence of PRRSV infection, by use of methods provided by the invention. The invention also provides articles of manufacture as well as kits comprising these oligonucleotides which may be used in the detection methods of the invention.
(FR)L'invention concerne des compositions et des procédés pour la détection du syndrome dysgénésique et respiratoire du porc (SDRP). L'invention concerne des oligonucléotides renfermant des séquences complémentaires de celles des régions ORF 7 et 3'-UTR (région non traduite) du SDRP, que l'on peut utiliser pour détecter la présence des séquences du SDRP, et donc la présence de l'infection par le SDRP, via les procédés décrits. L'invention concerne également des produits et des kits renfermant les oligonucléotides, pouvant être utilisés en liaison avec les procédés considérés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)